Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reinhard Zeidler

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Apoptosis : an International Journal on Programmed Cell Death|September 12, 2007
Nicotine and apoptosisReinhard Zeidler, Kaj Albermann, Stephan Lang
Cancer Letters|June 1, 2005
The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABPMarkus Münz, Reinhard Zeidler, Olivier Gires
Cancer Genomics & Proteomics|November 13, 2007
Molecular profiling for the identification of new biomarkers in smokers and cancer patientsKaj Albermann, Stephan Lang, Reinhard Zeidler
Journal of Extracellular Vesicles|February 22, 2019
Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLLKathrin Gärtner, Manja Luckner, Gerhard Wanner, et al.
Plos Pathogens|May 23, 2012
The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and eliminationSimon Jochum, Andreas Moosmann, Stephan Lang, et al.
Virology Journal|June 12, 2012
Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivoRomana Ruiss, Shinji Ohno, Beatrix Steer, et al.
Anticancer Research|August 21, 2003
Cloning and characterisation of a 1.1 kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoterOlivier Gires, Sylvia Eskofier, Stephan Lang, et al.
Anticancer Research|November 29, 2005
Prednisolone reduces TNF-alpha release by PBMCs activated with a trifunctional bispecific antibody but not their anti-tumor activityAnnette Walz, Michaela Andratschke, Barbara Wollenberg, et al.
Plos One|October 25, 2011
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLLRomana Ruiss, Simon Jochum, Ralph Mocikat, et al.
Plos Pathogens|June 13, 2015
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T CellsChiara Rancan, Leah Schirrmann, Corinna Hüls, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Apoptosis : an International Journal on Programmed Cell Death|September 12, 2007
Nicotine and apoptosisReinhard Zeidler, Kaj Albermann, Stephan Lang
Cancer Letters|June 1, 2005
The tumour-associated antigen EpCAM upregulates the fatty acid binding protein E-FABPMarkus Münz, Reinhard Zeidler, Olivier Gires
Cancer Genomics & Proteomics|November 13, 2007
Molecular profiling for the identification of new biomarkers in smokers and cancer patientsKaj Albermann, Stephan Lang, Reinhard Zeidler
Journal of Extracellular Vesicles|February 22, 2019
Engineering extracellular vesicles as novel treatment options: exploiting herpesviral immunity in CLLKathrin Gärtner, Manja Luckner, Gerhard Wanner, et al.
Plos Pathogens|May 23, 2012
The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and eliminationSimon Jochum, Andreas Moosmann, Stephan Lang, et al.
Virology Journal|June 12, 2012
Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivoRomana Ruiss, Shinji Ohno, Beatrix Steer, et al.
Anticancer Research|August 21, 2003
Cloning and characterisation of a 1.1 kb fragment of the carcinoma-associated epithelial cell adhesion molecule promoterOlivier Gires, Sylvia Eskofier, Stephan Lang, et al.
Anticancer Research|November 29, 2005
Prednisolone reduces TNF-alpha release by PBMCs activated with a trifunctional bispecific antibody but not their anti-tumor activityAnnette Walz, Michaela Andratschke, Barbara Wollenberg, et al.
Plos One|October 25, 2011
EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells--a new option for the treatment of B-CLLRomana Ruiss, Simon Jochum, Ralph Mocikat, et al.
Plos Pathogens|June 13, 2015
Latent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T CellsChiara Rancan, Leah Schirrmann, Corinna Hüls, et al.
Pageof 7